BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29801146)

  • 21. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

  • 22. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
    Kwiatkowski M; Klotz L; Hugosson J; Recker F
    Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
    [No Abstract]   [Full Text] [Related]  

  • 24. Counseling Patients About Prostate Cancer Screening.
    Stevermer JJ; Fink KS
    Am Fam Physician; 2018 Oct; 98(8):478-483. PubMed ID: 30277734
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.
    Pini G; Collins J; Ghadjar P; Wiklund P
    Curr Urol Rep; 2015 May; 16(5):28. PubMed ID: 25773347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discuss prostate cancer screening with your doctor.
    The Lancet
    Lancet; 2017 Apr; 389(10079):1582. PubMed ID: 28443541
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice.
    Giri VN; Hyatt C; Leader A
    J Urol; 2020 Dec; 204(6):1116-1118. PubMed ID: 32926644
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 29. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 30. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials.
    Goodwin JS; Tan A; Jaramillo E; Kuo YF
    J Natl Cancer Inst; 2013 May; 105(10):743-5. PubMed ID: 23459245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing the 2010 American Cancer Society prostate cancer screening guideline.
    Brawley OW; Gansler T
    CA Cancer J Clin; 2010; 60(2):68-9. PubMed ID: 20200111
    [No Abstract]   [Full Text] [Related]  

  • 33. PHE guidance does warn about PSA testing.
    Fenton K; Mackie A
    BMJ; 2016 Aug; 354():i4238. PubMed ID: 27496163
    [No Abstract]   [Full Text] [Related]  

  • 34. Rationale for earlier and less frequent prostate cancer screening.
    Carter HB
    Urology; 2001 Nov; 58(5):639-41. PubMed ID: 11711328
    [No Abstract]   [Full Text] [Related]  

  • 35. Current guidelines for prostate cancer screening: A systematic review and minimal core proposal.
    Araujo FAGDR; Oliveira U
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):290-296. PubMed ID: 29641784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for prostate cancer: time to put all the data on the table.
    Haines IE; Ablin RJ; Miklos GL
    BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
    [No Abstract]   [Full Text] [Related]  

  • 37. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 39. Reevaluating PSA Testing Rates in the PLCO Trial.
    Shoag JE; Mittal S; Hu JC
    N Engl J Med; 2016 May; 374(18):1795-6. PubMed ID: 27144870
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.